ACHP Letter to FDA Commissioner Dr. Makary
ACHP sent a letter to FDA Commissioner, Dr. Marty Makary, with comments on addressing high prescription drug costs & fostering a more competitive market.
ACHP sent a letter to FDA Commissioner, Dr. Marty Makary, with comments on addressing high prescription drug costs & fostering a more competitive market.
ACHP released a statement regarding the confirmation of Dr. Marty Makary as Commissioner of the U.S. Food and Drug Administration.
ACHP calls on Congress to create a national risk pool for cutting-edge cell and gene therapies to mitigate high costs and ensure the right patients have access at a manageable cost.
ACHP represents the nation’s top-performing nonprofit health companies, which serve tens of millions of Americans across nearly 40 states and D.C. ACHP member plans collaborate with providers on high-quality coverage and care — leading the industry in practical reforms.
This infographic breaks down how extending enhanced subsidies protects affordable individual coverage and care.
